Pathologic Disparities Between Peripheral Artery Disease and Coronary Artery Disease

Arterioscler Thromb Vasc Biol. 2020 Sep;40(9):1982-1989. doi: 10.1161/ATVBAHA.119.312864. Epub 2020 Jul 16.

Abstract

Atherosclerosis is a systemic disease that involves multiple vascular beds. The pathological characteristics and clinical presentation, however, vary among the different vascular territories. Acute coronary syndrome is a relatively common manifestation of coronary atherosclerotic disease, wherein the thrombosis occurs secondary to disruption (65%-75%) and erosion (25%-35%) of the fibrous caps of atheromatous plaques. The plaques associated with plaque rupture have large necrotic cores and thin and inflamed fibrous caps. However, the pathological manifestations of peripheral artery disease result from thrombosis regardless of the extent of atherosclerosis. Approximately 75% of peripheral arteries with significant stenosis demonstrate presence of thrombi, of which two-thirds have thrombi associated with insignificant atherosclerosis. The presence of obliterative thrombi in peripheral arteries of patients with critical limb ischemia in the absence of coronary artery-like lesions suggests a locally thrombogenic or remotely embolic basis of disease. Extensive calcification of the medial vascular layer is commonly observed. In this review, we have described and compared the pathological basis of coronary and peripheral artery disease in patients with acute coronary syndrome and critical limb ischemia. It is expected that pathogenetic characterization would allow for definition of strategic targets for superior management of peripheral artery disease.

Keywords: acute coronary syndrome; atherosclerosis; coronary artery disease; embolism; gangrene; thrombosis; vascular calcification.

Publication types

  • Review

MeSH terms

  • Acute Coronary Syndrome / drug therapy
  • Acute Coronary Syndrome / epidemiology
  • Acute Coronary Syndrome / pathology*
  • Arteries / drug effects
  • Arteries / pathology*
  • Coronary Artery Disease / drug therapy
  • Coronary Artery Disease / epidemiology
  • Coronary Artery Disease / pathology*
  • Coronary Vessels / pathology
  • Critical Illness
  • Disease Progression
  • Fibrinolytic Agents / therapeutic use
  • Fibrosis
  • Humans
  • Ischemia / pathology*
  • Peripheral Arterial Disease / drug therapy
  • Peripheral Arterial Disease / epidemiology
  • Peripheral Arterial Disease / pathology*
  • Plaque, Atherosclerotic*
  • Prognosis
  • Rupture, Spontaneous
  • Thrombosis / drug therapy
  • Thrombosis / epidemiology
  • Thrombosis / pathology*

Substances

  • Fibrinolytic Agents